The government is to sell Plasma Resources and could have made an offer to Spanish plasma product maker Grifols, according to Spanish daily Expansion.
The UK has hired investment bank Lazard to help sell its state-owned plasma company, which is valued between £200-300m.
German company Biotest is cited as a potential bidder, as is Grifols. However, the Spanish company is concerned about competition regulation problems.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In a statement last week, UK Health Minister Dan Poulter said, "We are taking this action to secure a viable future of the company and its employees in the long term and to ensure that patients will continue to have access to high-quality medical products.
"No final decisions about this sale have been made and the Department of Health may continue to retain a stake in the business. We will choose the best offer to ensure that high-quality medical products continue to be available to patients."
By 09:15, shares of Grifols were up 0.54% to €24.13.
LS
-
Should you sell in May this year?The market adage looks unlikely to apply in 2024, and global equities are proving resilient
-
Should you invest in UK equities?The FTSE 100 hit a record high this week, but UK equities remain unloved and undervalued compared to their global and US peers. Should you snap them up at a discount?
